Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Confluent (NASDAQ:CFLT) is gearing up to announce its quarterly earnings on Monday, 2025-10-27. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
Yes, it’s boring, but what you eat and drink does make a big difference to the eye area. Those who have ever woken up the ...
Fintel reports that on October 28, 2025, Evercore ISI Group maintained coverage of Confluent (NasdaqGS:CFLT) with a Outperform recommendation. Analyst Price Forecast Suggests 7.54% Upside As of ...
Citi analyst Tyler Radke raised the firm’s price target on Confluent (CFLT) to $48 from $45 and keeps a Neutral rating on the shares. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback